The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

The ENFUMOSA Study Group

Source: Eur Respir J 2003; 22: 470-477
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003; 22: 470-477

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Multi-symptom asthma as an indication of disease severity in epidemiology
Source: Eur Respir J 2011; 38: 825-832
Year: 2011

Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007

Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma
Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021
Year: 2021

Respiratory symptoms and CRP among participants of the English longitudinal study of ageing (ELSA) – ageing or occult disease?
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007

Comorbid conditions reported in patients with COPD recruited into a global clinical trial (UPLIFT)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005

The characteristics of ACOS in a population based asthma cohort
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016

The effect of smoking on lung function: a clinical study of adult-onset asthma
Source: Eur Respir J 2016; 48: 1298-1306
Year: 2016

The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013

A multicentre cohort study on the association between common markers of asthma and the incidence of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 295s
Year: 2006

Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001

Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2011; 38: 1261-1277
Year: 2011

Longitudinal changes in the nature, severity and frequency of COPD exacerbations
Source: Eur Respir J 2003 Dec 01;22(6):931-936
Year: 2003

Symptom variability in patients with severe COPD: a pan-European cross-sectional study
Source: Eur Respir J 2011; 37: 264
Year: 2011

The characteristics of work-related asthma in a prospective asthma cohort
Source: International Congress 2016 – Occupational epidemiology
Year: 2016

Asthma health status is better reflected by asthma control than by asthma severity in Asian patients - a prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 284s
Year: 2003

The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012

Two novel, severe asthma phenotypes identified during childhood using a clustering approach
Source: Eur Respir J 2012; 40: 55-60
Year: 2012

Incidence and etiology of adult asthma in general population
Source: Annual Congress 2005 - Cleaning and cooking: a risk for occupational and household asthma
Year: 2005

A prospective study of asthma incidence and its predictors: the RHINE study
Source: Eur Respir J 2004; 24: 942-946
Year: 2004

COPD specific comorbidities: A prospective, objective and controlled evaluation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016